Le Lézard
Classified in: Health
Subjects: NPT, AVO

NJHA Advocates for Opioid Crisis Solutions in D.C.


PRINCETON, N.J., March 14, 2018 /PRNewswire-USNewswire/ -- Members and staff of the New Jersey Hospital Association were in Washington, D.C., today to advocate for a multi-pronged solution to the opioid epidemic facing the country.

A priority among the legislative tools available is the Alternatives to Opioids (ALTO) in the Emergency Department Act, based on a model pioneered in New Jersey to promote alternative pain management protocols to limit the use of opioids in hospital emergency departments. The ALTO program was developed at St. Joseph's University Medical Center, in Paterson, and has shown a total reduction of 82 percent of opioid use in the emergency department in two years.

The legislation would provide grant funding to build ALTO demonstration programs in other areas. Following completion of the program the Secretary of Health and Human Services will submit a report to Congress on the results and issue recommendations for broader implementation.

U.S. Sens. Cory A. Booker (D-N.J.), Shelley Moore Capito (R-W.Va.), Michael F. Bennet (D-Colo.) and Cory Gardner (R-Colo.) along with U.S. Representatives Bill Pascrell Jr. (D-N.J.), David B. McKinley (R-W. Va.), Diana DeGette (D-Colo.) and Scott R. Tipton (R-Colo.) introduced the bill to help boost hospitals' resources in the fight against opioid addiction.

The NJHA delegation also advocated for these additional solutions:

"We are grateful that our elected representatives are working with us to curb the opioid crisis and ensure access to treatment and care for those who are suffering," said Sean Hopkins, senior vice president of federal relations and health economics for NJHA. "No one program or organization will solve this issue; we must all work together for the health of our state and nation."

In addition to speaking with the New Jersey delegation on the opioid epidemic, the group addressed federal concerns including cuts to the 340B drug pricing program, which helps hospitals provide care for low-income patients; cuts to the Public Service Loan Forgiveness program, which reduces or eliminates student debt for providers who practice in underserved communities; the Graduate Medical Education program; and support for legislation that would reduce paperwork redundancy and increase access to home healthcare.

Representatives from Atlantic Health System, Capital Health, Christian Health Care Center, Cooper University Health Care, Hackensack Meridian Health, St. Joseph's Health and Virtua joined NJHA staff in the Nation's Capital to speak with the members of Congress representing their facilities.

NJHA is a not-for-profit trade association committed to helping its members provide quality, affordable, accessible healthcare to their communities.

SOURCE New Jersey Hospital Association (NJHA)


These press releases may also interest you

at 12:53
Sports nutrition and lifestyle brand Bucked Up launched its Babe by Bucked Up line last October with a desire to create supplements made by women, for women. With its official launch now six months underway, Babe has become a huge sensation and...

at 12:05
VirtualHealth is excited to share that its HELIOS platform was named the winner of a Bronze Stevie® Award in the Healthcare Technology Solution category in The 22nd Annual American Business Awards® today. More than 3,700 nominations were submitted...

at 12:02
On May 1, 2024, Toronto Public Health (TPH) will host Diverse Dialogues: Stigma & Breaking Barriers. The event will bring together distinguished speakers to explore the challenging and thought-provoking topic about how negative labels and biases...

at 11:56
As the demand for cosmetic procedures continues to rise, patients are seeking more advanced and effective options for achieving a youthful and rejuvenated appearance. In response to this, Dr. Ronald Demeo has introduced the Next Level Deep Plane Face...

at 11:50
Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company") today reported its 2023 consolidated annual financial results, as of December 31, 2023, and provided financial information (unaudited)...

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...



News published on and distributed by: